<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20181226042142N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-03-16</date_registration>
      <primary_sponsor>Arak University of Medical Sciences</primary_sponsor>
      <public_title>The effect of topical use of bupivacaine and dexamethasone in tonsilar cavity in order to reduce pain after tonsillectomy</public_title>
      <acronym></acronym>
      <scientific_title>The effect of topical use of bupivacaine and dexamethasone in tonsilar cavity in order to reduce pain after tonsillectomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-05-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/38116</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: This study is a randomized, double-blind clinical trial for patients undergoing tonsillectomy in Amirkabir Hospital.
A total of 60 patients candidates for Tonsillectomy were randomly divided into two equal groups that using gases soaked dexamethasone and bupivacaine , or normal-saline in order to insert in the tonsilar cavity , Blinding description: In this study, only an otolaryngologist who is responsible for the study is aware of the type of study and the studied groups, while the patients , are not aware.also intern responsible for the plan that is responsible for filling the questionnaire ; it is not aware of the type of groups in terms of impacted drugs, and only knows the groups based on A and B, and fills the questionnaire on the basis of it.</study_design>
      <phase>3</phase>
      <hc_freetext>The Effect of Topical Use of Bupivacaine and Dexamethasone in Tonsilar Cavity in order to Reduce Pain After Tonsillectomy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After obtaining informed consent, 30 patients immediately after tonsillectomy place a gas soaked with bupivacaine and dexamethasone into the tonsillar cavity of each side for 10 minutes. In patients, they are given a  1 mg / kg of solution of bupivacaine 0.5 percent plus 1 mg of dexamethasone per kilogram (maximum 8 mg dexamethasone) and use normal saline to bring it to 10 cc and transfer to 2 gases and immediately after the tonsillectomy put it in the tonsillar cavity for ten minutes .Then, the pain score of patients in each of the two groups was measured in three replicates at 12 hours, 24 hours and one week after the intervention based on the checklist prepared. Intervention 2: Control group: After obtaining informed consent, 30 patients immediately after tonsillectomy, place a gas soaked with 10 cc normal saline in the tonsilar cavity of each side. Then, the pain levels of the patients in the two groups,measured in three replicates, 12 hours later ,24 hours later and one week after the intervention based on the checklist.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammadreza Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 29, Shahid Hamid Reza Shamsi Avenue,Imam Khomeini Street</address>
        <city>Khomein</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3881963356</zip>
        <telephone>+98 86 4633 5314</telephone>
        <email>www.mm80091@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammadreza Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 29, Shahid Hamid Reza Shamsi Avenue,Imam Khomeini Street</address>
        <city>Khomein</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3881963356</zip>
        <telephone>+98 86 4633 5314</telephone>
        <email>www.mm80091@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with frequent pharyngitis
Patients with complaints of chronic bad breath and sore throat
Patients with chronic tonsillitis</inclusion_criteria>
      <agemin>2 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Coagulation disorders in patients
Suspect malignancy
Asymmetric of tonsiles</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J35</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic diseases of tonsils and adenoids</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After obtaining informed consent, 30 patients immediately after tonsillectomy place a gas soaked with bupivacaine and dexamethasone into the tonsillar cavity of each side for 10 minutes. In patients, they are given a  1 mg / kg of solution of bupivacaine 0.5 percent plus 1 mg of dexamethasone per kilogram (maximum 8 mg dexamethasone) and use normal saline to bring it to 10 cc and transfer to 2 gases and immediately after the tonsillectomy put it in the tonsillar cavity for ten minutes .Then, the pain score of patients in each of the two groups was measured in three replicates at 12 hours, 24 hours and one week after the intervention based on the checklist prepared.</i_keyword>
      <i_keyword>Control group: After obtaining informed consent, 30 patients immediately after tonsillectomy, place a gas soaked with 10 cc normal saline in the tonsilar cavity of each side. Then, the pain levels of the patients in the two groups,measured in three replicates, 12 hours later ,24 hours later and one week after the intervention based on the checklist.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Intensity of pain. Timepoint: 12 hours later and 24 hours later and one week after the intervention. Method of measurement: Based on checklist.</prim_outcome>
      <prim_outcome>Number of nausea and vomiting. Timepoint: 12 hours later and 24 hours later and one week after the intervention. Method of measurement: Based on checklist.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Arak University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-02-24</approval_date>
        <contact_name>Ethics Committee of Arak University of Medical Sciences</contact_name>
        <contact_address>Sardasht - Basij Square- Arak University of Medical Sciences Arak Markazi Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
